[1] SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5.
[2] CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115.
[3] MASLIAH-PLANCHON J,BIÈCHE I,GUINEBRETIÈRE JM,et al.SWI/SNF chromatin remodeling and human malignancies[J].Annu Rev Pathol,2015,10(1):145.
[4] MATSUBARA D,KISHABA Y,ISHIKAWA S,et al.Lung cancer with loss of BRG1/BRM,shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features[J].Cancer Sci,2013,104(2):266.
[5] DAMIANO L,STEWART KM,COHET N,et al.Oncogenic targeting of BRM drives malignancy through C/EBP β-dependent induction of α5 integrin[J].Oncogene,2014,33(19):2441.
[6] XIA QY,RAO Q,CHENG L,et al.Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma[J].Histopathology,2014,64(6):847.
[7] GRAMLING S,ROGERS C,LIU G,et al.Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM:a novel targeted treatment strategy[J].Oncogene,2011,30(29):3289.
[8] LIU G,GRAMLING S,MUNOZ D,et al.Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk[J].Oncogene,2011,30(29):3295.
[9] GAO X,HUANG M,LIU L,et al.Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations[J].PLoS One,2013,8(1):e55169.
[10] LIANG Q,WEN D,XIE J,et al.A rapid and effective method for silver staining of PCR products separated in polyacrylamide gels[J].Electrophoresis,2014,35(17):2520.
[11] 陆云霞,施侣元,余红平,等.武汉居民饮食模式与食管癌发病关系的条件Logistic回归分析[J].中国卫生统计,2005,22(3):146.
[12] 姚风一.食管癌发病因素的研究[J].中华流行病学杂志,1986,7(2):70.
[13] 沈月平,高玉堂,戴奇,等.淮安市食管癌病例对照研究[J].肿瘤,1999,19(6):363.
[14] 彭仙娥,周紫荆,史习舜,等.安溪县食管癌发病影响因素病例对照研究[J].中国公共卫生,2005,21(1):10.
[15] 刘新民,王庆生,张亚黎,等.吸烟、饮酒与男性食管癌关系的病例对照研究[J].天津医科大学学报,2000,6(3):280.
[16] YANIV M.Chromatin remodeling:from transcription to cancer[J].Cancer Genet,2014,207(9):352.
[17] KOBAYASHI K,SAKURAI K,HIRAMATSU H,et al.The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines[J].Sci Rep,2015,5(1):8428.
[18] HOFFMAN GR,RAHAL R,BUXTON F,et al.Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers[J].Proc Natl Acad Sci USA,2014,111(8):3128.